A new study published in the JAMA revealed that among patients who underwent transcatheter aortic valve replacement (TAVR), the death rate after one year was nearly one in four; of those alive at 12 months, almost half had not been re-hospitalized and approximately 25 percent had only one hospitalization.
TAVR has been used with increasing frequency for the treatment of severe aortic stenosis in patients who have high risks with conventional surgical AVR. TAVR is a less invasive procedure than open heart-valve surgery and involves replacing the aortic valve using a catheter inserted in the patient's groin.
Aortic Valve Stenosis
Aortic valve Stenosis is an abnormal narrowing of the c valve. Symptoms include angina, and that of heart failure. Aortic valve replacement is effective therapy.
Advertisement
The median age of the study patients was 84 years and 52 percent were women. Following the TAVR procedure, 60 percent were discharged and the 30-day mortality rate was 7.0 percent. At the end of 1 year, the overall mortality rate was 24 percent, the stroke rate was 4.1 percent, and the rate of the composite outcome of mortality and stroke was 26 percent. Also, 47 percent of patients who remained alive at 12 months had not been re-hospitalized, 24 percent were re-hospitalized once and 12.5 percent were re-hospitalized twice. Re-admission for a composite of stroke, heart failure, or repeat aortic valve intervention occurred in 19 percent of patients. Characteristics significantly associated with 1-year mortality among patients included advanced age, male sex, end-stage renal disease and severe chronic obstructive pulmonary disease. As compared with men, women had a higher risk of stroke.
The authors said, "The rate of l-year mortality reported with this registry is similar to that in other comprehensive reports. Although this study includes only patients considered to have high risks with AVR, the majority of this mortality does not represent periprocedural complications, as 30-day mortality was only 7.0 percent. As such, this makes it imperative to focus on better prediction of the overall risks and benefits of the procedure, particularly given the existing comorbidities of the group of patients being considered for TAVR. It may be possible to identify patients who may not benefit from this procedure and who should be counseled accordingly."
![New Approach: Aortic Valve Implantation Combined With Coronary Artery Stenting]( "New Approach: Aortic Valve Implantation Combined With Coronary Artery Stenting")
Aortic stenosis is a condition where the valve at the junction of the left ventricle and the aorta, the largest blood vessel of the body, is narrowed.
The researchers wrote, "Although 3 randomized trials and multiple single-center and multi-center registry studies have been published, the profile and longer-term outcomes of U.S. TAVR cases in routine clinical practice remains limited. These findings should be helpful in discussions with patients undergoing TAVR."
Source: Medindia
New Approach: Aortic Valve Implantation Combined With Coronary Artery Stenting
Aortic stenosis is a condition where the valve at the junction of the left ventricle and the aorta, the largest blood vessel of the body, is narrowed.
Advertisement
The researchers wrote, "Although 3 randomized trials and multiple single-center and multi-center registry studies have been published, the profile and longer-term outcomes of U.S. TAVR cases in routine clinical practice remains limited. These findings should be helpful in discussions with patients undergoing TAVR."
Source: Medindia
Aortic Stenosis Risk Doubled by Family History
It is well-known among clinicians that aortic stenosis is the most common heart valve disease in the elderly and is often caused by calcification of a normal valve.
Advertisement
 Quality of Life in Patients With Severe Aortic Stenosis Improved by TAVIA new study has indicated that a procedure called transcatheter aortic valve implantation leads to meaningful improvements in health-related quality of life in patients with severe aortic stenosis | Advertisement
|
Advertisement
